Santhera Pharmaceuticals Holding AG
Research Santhera Pharmaceuticals Holding AG (SANN) on Bullrun: market cap CHF 243.94M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSANN
- ExchangeSW
- CountrySwitzerland
- SectorHealthcare
- IndustryBiotechnology
- CurrencyCHF
- Market capCHF 243.94M
- Financial periodFY2025
- RevenueCHF 77.19M
- Revenue growth97.3%
- Net income-CHF 49.24M
- Free cash flow-CHF 34.82M
- Gross margin19.7%
Valuation Snapshot
latest market cap is CHF 243.94M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CHF 77.19M | -CHF 49.24M | -CHF 34.82M | 19.7% | -3.78 | CHF 22.44M | CHF 48.95M | -CHF 11.82M |
| FY2024 | CHF 39.12M | -CHF 41.97M | -CHF 35.68M | 60.3% | -3.69 | CHF 40.93M | CHF 40.62M | CHF 27.70M |
| FY2023 | CHF 103.41M | CHF 54.78M | CHF 23.53M | 96.9% | 5.01 | CHF 30.37M | CHF 21.55M | CHF 59.94M |
| FY2022 | CHF 7.47M | -CHF 71.08M | -CHF 33.80M | 51.9% | -11.67 | CHF 1.35M | CHF 44.44M | -CHF 43.69M |
| FY2021 | -CHF 1.60M | -CHF 55.53M | -CHF 37.37M | 336.2% | -16.2 | CHF 21.21M | CHF 42.98M | CHF 1.33M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-14 | CHF 243.94M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 CHF.
About Santhera Pharmaceuticals Holding AG
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company's lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Santhera Pharmaceuticals Holding AG's market cap?
Santhera Pharmaceuticals Holding AG's market capitalization is CHF 243.94M.
What does Santhera Pharmaceuticals Holding AG do?
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company's lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.